| Healthy Subjects (n = 43) | All MPD Patients (n = 24) | Polycythemia Vera (n = 11) | Essential Thrombocytosis (n = 13) | G-CSF-Treated Subjects (n = 27) |
---|---|---|---|---|---|
% Reactive cells | |||||
CD11b | 55 ± 26 | 54 ± 28 | 66 ± 27 | 44 ± 26†| 64 ± 24 |
CD15 | 21 ± 25 | 50 ± 31*†| 51 ± 31*†| 49 ± 33*†| 23 ± 29 |
CD16 | 81 ± 22 | 82 ± 19 | 83 ± 24 | 82 ± 16 | 89 ± 5 |
CD18 | 48 ± 33 | 73 ± 26* | 73 ± 30* | 73 ± 23* | 62 ± 35 |
CD177 | 53 ± 23 | 59 ± 28†| 59 ± 29†| 58 ± 27†| 82 ± 26* |
Mean Fluorescence Intensity | |||||
CD11b | 182 ± 51 | 187 ± 107 | 171 ± 100 | 200 ± 115 | 155 ± 67 |
CD15 | 480 ± 284 | 374 ± 236 | 373 ± 265 | 377 ± 221 | 441 ± 443 |
CD16 | 2,946 ± 1,345 | 2,580 ± 1,138†| 2,410 ± 1,430†| 2,725 ± 853†| 890 ± 336* |
CD18 | 451 ± 300 | 250 ± 81* | 267 ± 100 | 237 ± 61* | 253 ± 107* |
CD177 | 625 ± 383 | 575 ± 267†| 587 ± 251†| 566 ± 290†| 2,012 ± 1088* |